Pasco MIC and MIC/ID Panels, Gemifloxacin (Strep)
510(k) K032518
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK032518 | Date15 Sep 2003 | StatusActive |
Recalls
No FDA recalls found in the data synced 5 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- JWY
- Device Class
- Class II
- Regulation
- 21 CFR Part 866.1640
- Advisory Committee
- Microbiology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The Pasco MIC and MIC/ID Panels, Gemifloxacin (Strep) are manual antimicrobial susceptibility test systems designed for determining the minimum inhibitory concentration (MIC) of gemifloxacin against Streptococcus species. These frozen microdilution panels contain two-fold dilutions of the antimicrobial agent, enabling precise measurement of bacterial resistance or susceptibility through visible growth or colorimetric changes after incubation.
The panels are supplied frozen and require thawing before use. After inoculation with test organisms via a direct turbidity method, they are incubated for 16–24 hours at 35°C in a non-CO₂ environment. Classified as a Class II device under FDA regulations, these panels are intended for in vitro diagnostic use in microbiology laboratories. Each panel is single-use and must be stored according to manufacturer guidelines to maintain integrity.
Other devices from Bd Diagnostic Systems
Questions
AI-generated answers, 1 Oct 2026
What is the Pasco MIC and MIC/ID Panels, Gemifloxacin (Strep) used for?
These panels are designed to determine the minimum inhibitory concentration (MIC) of gemifloxacin against Streptococcus species. By measuring bacterial growth or colorimetric changes after incubation, clinicians can assess whether an organism is resistant or susceptible to the antibiotic. This helps guide appropriate treatment decisions in microbiology labs.
How are the Pasco Gemifloxacin MIC/ID Panels supplied and prepared for use?
The panels are supplied frozen and must be thawed before use. After thawing, they are inoculated with test organisms using a direct turbidity method. Incubation occurs for 16–24 hours at 35°C in a non-CO₂ environment to observe results.
Are the Pasco Gemifloxacin MIC/ID Panels single-use or reusable?
Each panel is intended for single-use only. This ensures accuracy and sterility, as reuse could compromise the integrity of the antimicrobial dilutions and introduce contamination risks.
What storage conditions are required to maintain the panels’ integrity?
The panels must be stored according to the manufacturer’s guidelines to preserve their frozen state and prevent degradation. Improper storage could alter the antimicrobial dilutions, leading to unreliable MIC results.
What regulatory pathway does the Pasco Gemifloxacin MIC/ID Panels follow?
The device is classified as a Class II medical device under FDA regulations and has received 510(k) clearance through a traditional review process. It is intended for in vitro diagnostic use in microbiology laboratories.